Published 3 years ago

Johnson & Johnson booster shot prompts large increase in immune response, company says

Summary by Ground News

Booster doses of the coronavirus vaccine generated a big spike in antibodies, the company says. People who received a booster six to eight months after their initial J&J shots saw antibodies increase nine-fold higher than 28 days after the first shot. The data comes from two Phase 2 studies conducted in the United States and Europe.

0 Articles

All

Left

Center

Right

Times of India

Johnson & Johnson says booster dose increased antibodies in early-stage studies

A second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people received their first dose, the company said in a press release.

3 years ago·India

Read Full Article

Yahoo News

J&J says booster dose increased antibodies in early-stage studies

A second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people received their first dose, the company said in a press release. Unlike neutralizing antibodies, which destroy the virus, binding antibodies attach to the virus but do not destroy it or prevent infection. Several countries, including the United States, have begun offering booster doses https://www.reuters.com/a…

3 years ago·Los Angeles, United States

Read Full Article

News18 India

J&J Says Covid-19 Booster Dose Increased Antibodies in Early-stage Studies

A booster dose of Johnson & Johnson's COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said on Wednesday.

3 years ago·India

Read Full Article

The Guardian

Johnson & Johnson touts Covid booster shot as US grapples with rise in hospitalizations – live

J&J data shows booster produces ‘rapid and robust increase’ in antibodies while over 90% of ICU beds being used in states like Florida, Texas and Mississippi

3 years ago·London, United Kingdom

Read Full Article

CTV News

Johnson & Johnson booster shot prompts large increase in immune response, company says

Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company reported Wednesday.

3 years ago·Canada

Read Full Article

Reuters

J&J says booster dose increased antibodies in early-stage studies

By Julie Steenhuysen CHICAGO - A booster dose of Johnson & Johnson's COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company said on Wednesday. A second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days after people received their first dose, the company

3 years ago·United Kingdom

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.